Navigation Links
Bath Salts: With Dangerous Drug Use on the Rise, Ameritox Launches Critical New Test to Help Detect Designer Drug
Date:7/11/2012

BALTIMORE, July 11, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in pain medication monitoring, today announced that it has developed a test to detect "bath salts," a class of drugs being created in chemistry labs with the purpose of bypassing laws and providing a "legal high."

Though the Drug Enforcement Administration currently includes three synthetic cathinones – known on the street as "bath salts" or "plant food" – on its list of banned Schedule 1 drugs, Ameritox scientists have formulated tests that screen for five additional chemical compositions. This level of screening for bath salts puts Ameritox at the forefront of other pain medication monitoring labs.

Structurally and pharmacologically similar to amphetamine, methamphetamine, and MDMA ("Ecstasy"), synthetic cathinones, or bath salts, are laboratory-created versions of a controlled substance. These substances, however, have no legitimate bathing use, in contrast to Epsom salts. In what some have called a "chemical cat and mouse game," new versions of bath salts are continuously produced with a slightly altered molecular structure to avoid being classified as illicit drugs.

"Physicians know the dangers of combining dangerous substances with powerful prescription painkillers," said Harry Leider, MD, Chief Medical Officer of Ameritox.  "Assuring patient safety has taken on new, high-stakes challenges with the proliferation of these designer drugs. Many of these laboratory concoctions are so new they are not yet illegal – but are still extremely dangerous."

Bath salts are said to affect users similarly to methamphetamine, with side effects that can include agitation, combative behavior, hallucinations, paranoia, anxiety, seizures and palpitations.

Deaths related to the use of bath salts have occurred in numerous states in recent weeks and poisonings have jumped. In 2011, the National Poison Control Centers received over 6,000 calls about synthetic cathinones, compared to only 300 in 2010.

Bath salts are widely available for $25 to $60 a packet at convenience stores and smoke shops, and the U.S. government has mobilized to combat their rising abuse. In June 2011, the DEA placed three specific synthetic cathinones into its Schedule 1 category of controlled substances, citing the move as "necessary to avoid imminent hazard to the public safety" due to high abuse potential and lack of medical use.

According to DEA, synthetic cathinones are falsely marketed as "research chemicals," "plant food," or "bath salts." Packages usually have the warning "not for human consumption," most likely in an effort to circumvent statutory restrictions for these substances. Common brand names for these are Purple Rain, Cloud 9, White Rush and Scarface.

Ameritox has developed tests for bath salts that not only detect three common synthetic cathinones that the DEA categorized as controlled substances, but also tests for five other chemical components commonly used in bath salts products.

"These basement chemists will almost certainly alter their formulas to stay one step ahead of the law and urine drug testing, but Ameritox is just as focused on leveraging our state-of-the-art laboratory capabilities to meet the growing dangers posed by the emergence of designer drugs," said Leider. "We know that to best support the efforts of physicians to reduce drug misuse and abuse, our scientific research has to remain leading edge."

For additional information, visit www.ameritox.com.

About AmeritoxAmeritox is the nation's leader in Pain Medication Monitoring Solutions®, offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers the most thorough pain medication monitoring lab process – Rx Guardian(SM) – with Rx Guardian CD(SM), the only pain medication monitoring process with a proprietary normalization algorithm and a reference database of pain patients clinically assessed for adherence. Patient results are compared against this database, helping physicians assess whether patients are taking their pain medications correctly. Monitoring through prescription drug testing helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, Md. with laboratory facilities in Midland, Texas and Greensboro, N.C. Ameritox can be found online at www.ameritox.com, on Twitter @Ameritox, on Facebook at facebook.com/ameritox, and on YouTube at www.youtube.com/ameritox.

© 2012 Ameritox Ltd. All rights reserved. Ameritox, Ameritox-Medication Monitoring Solutions, Rx Guardian, Rx Guardian INSIGHT and Rx Guardian CD are trademarks of Ameritox. Other trademarks are the property of their owners.For more information, contact:

Lon Wagner Ameritox336-387-7742Lon.Wagner@ameritox.com 


'/>"/>
SOURCE Ameritox
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dangerous Medical Device Loophole Puts Patients At Risk
2. PeriGen, Inc. Launches Consumer Safety Campaign to Raise Awareness of Dangerous Birth Complication
3. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
4. Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues
5. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
6. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
7. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
8. Mylan Launches Generic Version of Zyprexa® Tablets
9. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
10. American Academy of Family Physicians Foundation Launches Cities for Life
11. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):